Inactivation of DNA repair—prospects for boosting cancer immune surveillance

by Anna Truini, Giovanni Germano, Alberto Bardelli
Published 2018-11-01

Activation of β-catenin by oncogenic PIK3CA and EGFR promotes resistance to glucose deprivation by inducing a strong antioxidant response.

by Luca Cardone, Alberto Bardelli, Vittorio Enrico Avvedimento
Published 2012-01-01

Exploring the links between cancer and placenta development

by Vincenzo Costanzo, Alberto Bardelli, Salvatore Siena, Sergio Abrignani
Published 2018-06-01

Exploiting DNA repair defects in colorectal cancer

by Nicole M. Reilly, Luca Novara, Federica Di Nicolantonio, Alberto Bardelli
Published 2019-04-01

Early‐onset colorectal cancer in young individuals

by Gianluca Mauri, Andrea Sartore‐Bianchi, Antonio‐Giampiero Russo, Silvia Marsoni, Alberto Bardelli, Salvatore Siena
Published 2019-02-01

Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.

by Vincenzo Corbo, Rossana Ritelli, Stefano Barbi, Niccola Funel, Daniela Campani, Alberto Bardelli, Aldo Scarpa
Published 2010-09-01

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

by Vito Amodio, Gianluca Mauri, Nicole M. Reilly, Andrea Sartore-Bianchi, Salvatore Siena, Alberto Bardelli, Giovanni Germano
Published 2021-05-01

Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance

by Moiez Ali, Erin Kaltenbrun, Grace R. Anderson, Sarah Jo Stephens, Sabrina Arena, Alberto Bardelli, Christopher M. Counter, Kris C. Wood
Published 2017-06-01

RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

by Simona Lamba, Mariangela Russo, Chong Sun, Luca Lazzari, Carlotta Cancelliere, Wipawadee Grernrum, Cor Lieftink, Rene Bernards, Federica Di Nicolantonio, Alberto Bardelli
Published 2014-09-01

Absence of AKT1 mutations in glioblastoma.

by Fonnet E Bleeker, Simona Lamba, Carlo Zanon, Angela A van Tilborg, Sieger Leenstra, Dirk Troost, Theo Hulsebos, W Peter Vandertop, Alberto Bardelli
Published 2009-05-01

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.

by Nicola Normanno, Carmine Pinto, Francesca Castiglione, Alberto Bardelli, Marcello Gambacorta, Gerardo Botti, Oscar Nappi, Salvatore Siena, Fortunato Ciardiello, Gianluigi Taddei, Antonio Marchetti
Published 2011-01-01

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

by Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth
Published 2016-01-01

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

by Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth
Published 2018-01-01

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

by Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth
Published 2017-01-01

CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

by Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth
Published 2016-01-01

Mutational profile of GNAQQ209 in human tumors.

by Simona Lamba, Lara Felicioni, Fiamma Buttitta, Fonnet E Bleeker, Sara Malatesta, Vincenzo Corbo, Aldo Scarpa, Monica Rodolfo, Margaret Knowles, Milo Frattini, Antonio Marchetti, Alberto Bardelli
Published 2009-08-01

PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs

by Anirudh Prahallad, Guus J.J.E. Heynen, Giovanni Germano, Stefan M. Willems, Bastiaan Evers, Loredana Vecchione, Valentina Gambino, Cor Lieftink, Roderick L. Beijersbergen, Federica Di Nicolantonio, Alberto Bardelli, Rene Bernards
Published 2015-09-01

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients

by Federica Morano, Filippo Pietrantonio, Giovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, Monica Montone, Alice Bartolini, Ludovic Barault, Antonia Martinetti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, Silvia Marsoni, Alberto Bardelli, Giulia Siravegna
Published 2019-11-01

Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer

by Annalisa Lorenzato, Alessandro Magrì, Vittoria Matafora, Valentina Audrito, Pamela Arcella, Luca Lazzari, Monica Montone, Simona Lamba, Silvia Deaglio, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Angela Bachi, Federica Di Nicolantonio, Alberto Bardelli, Sabrina Arena
Published 2020-03-01

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.

by Andrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, Francesca Molinari, Sara De Dosso, Piercarlo Saletti, Miriam Martini, Tiziana Cipani, Giovanna Marrapese, Luca Mazzucchelli, Simona Lamba, Silvio Veronese, Milo Frattini, Alberto Bardelli, Salvatore Siena
Published 2009-10-01